Differential expression of the IRF6 gene in the signs of Van der Woude Syndrome: Are distinct genetic modifiers operating?
DOI:
https://doi.org/10.5195/d3000.2021.164Keywords:
Van der Woude syndrome, Orofacial clefts, IRF6 geneAbstract
Objective: The purpose of this study was to report a new variant in the Interferon Regulatory Factor 6 gene (IRF6) and to determine phenotype-genotype correlations in a family segregating Van der Woude syndrome.
Methods: A five-generation family of 80 individuals segregating VWS was investigated using a tabulated pedigree but considering that three individuals registered in the pedigree died shortly after birth, the final sample size was 77 individuals. Five individuals had a complete dental clinical examination and molecular analysis performed using direct sequencing of the exon 4 and an adjacent region with 23 base pairs of the IRF6 gene.
Results: Features of VWS reported in family history were present in 36.4% (28/77) of all family members; of these 57% (16/28) had pits in the lower lip, 36% (10/28) had both pits and orofacial clefts and 7 % (2/28) had only orofacial clefts. Developmental dental anomalies were observed in three individuals. The sequence analysis of exon 4 of the IRF6 gene carried out for 4 family members revealed the presence of the SNP rs7552506 (c.175-5C> G) located in five base pairs before the start of exon. The analysis of exon 4 of the IRF6 gene also revealed a new variant c.269G>C (p.Ser90Thr) which causes exchange of the Serine amino acid residue for the Threonine residue.
Conclusions: The c.269G>C(p.Ser90Thr) can interfere with multimeric interactions and with protein conformation that will be slightly destabilized, because the mutant residue is bigger than the wild-type residue. The phenotypic variations in the cases studied, despite carrying the same genetic mutation, suggest that distinct genetic modifiers operate on the formation of clefts and dental development.
References
Cleft lip - a comprehensive review. Shkoukani MA, Chen M, Vong A. Front Pediatr. 2013 Dec. 53 (1): 1 - 10. PMID: 2440029.
Van der Woude syndrome: clinical presentation in 64 patients. Huang JJ, Hou JW, Tan YC, Chen KT, Lo LJ, Chen YR. Cleft Palate Craniofac J. 2007 Nov;44(6):649-52. PMID: 18177185.
Van der Woude syndrome: a review of 11 cases seen at the Lagos University Teaching Hospital. James O, Adeyemo WL, Emeka CI, Ogunlewe MO, Ladeinde AL, Butali A. Afr J Paediatr Surg. 2014 Jan-Mar;11(1):52-5. PMID: 24647295.
Van der Woude syndrome: a review. Cardinal signs, epidemiology, associated features, differential diagnosis, expressivity, genetic counselling and treatment. Rizos M, Spyropoulos MN. Eur J Orthod. 2004 Feb;26(1):17-24. PMID: 14994878.
The penetrance and variable expression of the Van der Woude syndrome: implications for genetic counseling. Shprintzen RJ, Goldberg RB, Sidoti EJ. Cleft Palate J. 1980 Jan;17(1):52-7. PMID: 6928118.
Epidemiology of Van der Woude syndrome from mutational analyses in affected patients from Pakistan. Malik S, Kakar N, Hasnain S, Ahmad J, Wilcox ER, Naz S. Clin Genet. 2010 Sep;78(3):247-56. PMID: 20184620.
Van der Woude syndrome: dentofacial features and implications for clinical practice. Lam AK, David DJ, Townsend GC, Anderson PJ. Aust Dent J. 2010 Mar;55(1):51-8. PMID: 20415912.
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y, Howard E, de Lima RL, Daack-Hirsch S, Sander A, McDonald-McGinn DM, Zackai EH, Lammer EJ, Aylsworth AS, Ardinger HH, Lidral AC, Pober BR, Moreno L, Arcos-Burgos M, Valencia C, Houdayer C, Bahuau M, Moretti-Ferreira D, Richieri-Costa A, Dixon MJ, Murray JC. Nat Genet. 2002 Oct;32(2):285-9. PMID: 12219090.
An etiologic regulatory mutation in IRF6 with loss- and gain-of-function effects. Fakhouri WD, Rahimov F, Attanasio C, Kouwenhoven EN, Ferreira De Lima RL, Felix TM, Nitschke L, Huver D, Barrons J, Kousa YA, Leslie E, Pennacchio LA, Van Bokhoven H, Visel A, Zhou H, Murray JC, Schutte BC. Hum Mol Genet. 2014 May 15;23(10):2711-20. PMID: 24442519.
Dominant mutations in GRHL3 cause Van der Woude Syndrome and disrupt oral periderm development. Peyrard-Janvid M, Leslie EJ, Kousa YA, Smith TL, Dunnwald M, Magnusson M, Lentz BA, Unneberg P, Fransson I, Koillinen HK, Rautio J, Pegelow M, Karsten A, Basel-Vanagaite L, Gordon W, Andersen B, Svensson T, Murray JC, Cornell RA, Kere J, Schutte BC. Am J Hum Genet. 2014 Jan 2;94(1):23-32. PMID: 24360809.
A preliminary gene map for the Van der Woude syndrome critical region derived from 900 kb of genomic sequence at 1q32-q41. Schutte BC, Bjork BC, Coppage KB, Malik MI, Gregory SG, Scott DJ, Brentzell LM, Watanabe Y, Dixon MJ, Murray JC. Genome Res. 2000 Jan;10(1):81-94. PMID: 10645953.
The IRF family of transcription factors: Inception, impact and implications in oncogenesis. Yanai H, Negishi H, Taniguchi T. Oncoimmunology. 2012 Nov 1;1(8):1376-1386. PMID: 23243601.
Maternal Interferon Regulatory Factor 6 is required for the differentiation of primary superficial epithelia in Danio and Xenopus embryos. Sabel JL, d'Alençon C, O'Brien EK, Van Otterloo E, Lutz K, Cuykendall TN, Schutte BC, Houston DW, Cornell RA. Dev Biol. 2009 Jan 1;325(1):249-62. PMID: 19013452.
Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S, Trout KJ, Malik MI, Dunnwald M, Goudy SL, Lovett M, Murray JC, Schutte BC. Nat Genet. 2006 Nov;38(11):1335-40. PMID: 17041601.
IRF family of transcription factors as regulators of host defense. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. Annu Rev Immunol. 2001;19: 623-55. PMID: 11244049.
Interferon Regulatory Factor 6 Is Necessary for Salivary Glands and Pancreas Development. Metwalli KA, Do MA, Nguyen K, Mallick S, Kin K, Farokhnia N, Jun G, Fakhouri WD. J Dent Res. 2018 Feb;97(2):226-236. PMID: 28898113.
Genealogical data in population medical genetics: Field guidelines.Poletta FA, Orioli IM, Castilla EE. Genet Mol Biol. 2014 Mar;37(1 Suppl):171-85. PMID: 24764752.
Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. BMC Bioinformatics. 2010 Nov 8;11:548. PMID: 21059217.
PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Choi Y, Chan AP. Bioinformatics. 2015 Aug 15;31(16):2745-7. PMID: 25851949.
SIFT web server: predicting effects of amino acid substitutions on proteins. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7. PMID: 22689647.
Predicting functional effect of human missense mutations using PolyPhen-2. Adzhubei I, Jordan DM, Sunyaev SR. Curr Protoc Hum Genet. 2013 Jan; Chapter 7:Unit7.20. PMID: 23315928.
Novel IRF6 mutations in families with Van Der Woude syndrome and popliteal pterygium syndrome from sub-Saharan Africa. Butali A, Mossey PA, Adeyemo WL, Eshete MA, Gaines LA, Even D, Braimah RO, Aregbesola BS, Rigdon JV, Emeka CI, James O, Ogunlewe MO, Ladeinde AL, Abate F, Hailu T, Mohammed I, Gravem PE, Deribew M, Gesses M, Adeyemo AA, Murray JC. Mol Genet Genomic Med. 2014 May;2(3):254-60. PMID: 24936515.
Clinical and genetic features of Van der Woude syndrome in two large families in Brazil. Martelli-Junior H, Chaves MR, Swerts MS, de Miranda RT, Bonan PR, Coletta RD. Cleft Palate Craniofac J. 2007 May;44(3):239-43. PMID: 17477759.
Congenital Symmetrical Lower Lip Pits: Van der Woude Syndrome. Ibrahim A, Ajike S. Oman Med J. 2015 Jan;30(1):e081. PMID: 30838101.
Wound complications after cleft repair in children with Van der Woude syndrome. Jones JL, Canady JW, Brookes JT, Wehby GL, L'Heureux J, Schutte BC, Murray JC, Dunnwald M. J Craniofac Surg. 2010 Sep;21(5):1350-3. PMID: 20856020.
The genetics of isolated orofacial clefts: from genotypes to subphenotypes. Jugessur A, Farlie PG, Kilpatrick N. Oral Dis. 2009 Oct;15(7):437-53. PMID: 19583827.
Gene/environment causes of cleft lip and/or palate. Murray JC. Clin Genet. 2002 Apr;61(4):248-56. PMID: 12030886.
Identification of IRF6 gene variants in three families with Van der Woude syndrome. Tan EC, Lim EC, Yap SH, Lee ST, Cheng J, Por YC, Yeow V. Int J Mol Med. 2008 Jun;21(6):747-51. PMID: 18506368.
Prevalence and nonrandom distribution of exonic mutations in interferon regulatory factor 6 in 307 families with Van der Woude syndrome and 37 families with popliteal pterygium syndrome. de Lima RL, Hoper SA, Ghassibe M, Cooper ME, Rorick NK, Kondo S, Katz L, Marazita ML, Compton J, Bale S, Hehr U, Dixon MJ, Daack-Hirsch S, Boute O, Bayet B, Revencu N, Verellen-Dumoulin C, Vikkula M, Richieri-Costa A, Moretti-Ferreira D, Murray JC, Schutte BC. Genet Med. 2009 Apr;11(4):241-7. PMID: 19282774.
Familial non-syndromic cleft lip and palate--analysis of the IRF6 gene and clinical phenotypes. Pegelow M, Peyrard-Janvid M, Zucchelli M, Fransson I, Larson O, Kere J, Larsson C, Karsten A. Eur J Orthod. 2008 Apr;30(2):169-75. PMID: 18209213.
Novel mutations in the IRF6 gene for Van der Woude syndrome. Wang X, Liu J, Zhang H, Xiao M, Li J, Yang C, Lin X, Wu Z, Hu L, Kong X. Hum Genet. 2003 Oct;113(5):382-6. PMID: 12920575.
Van der woude syndrome with short review of the literature. Deshmukh PK, Deshmukh K, Mangalgi A, Patil S, Hugar D, Kodangal SF. Case Rep Dent. 2014; 2014:871460. PMID: 25050184.
Hypoplasia and hypodontia in Van der Woude syndrome. Oberoi S, Vargervik K. Cleft Palate Craniofac J. 2005 Sep;42(5):459-66. PMID: 16149825.
Dental agenesis: genetic and clinical perspectives. De Coster PJ, Marks LA, Martens LC, Huysseune A. J Oral Pathol Med. 2009 Jan;38(1):1-17. PMID: 18771513.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Revised 7/16/2018. Revision Description: Removed outdated link.